RemedyBio is pleased to announce that it has completed its move to its new laboratory facilities at the Trinity Translational Medicine Institute- TTMI on the St James’s Hospital campus in Dublin 8. These new state-of-the-art equipped laboratories will house our talented and growing team of biologists and engineers, and also provide academic and clinical collaboration opportunities aligned with our mission to deliver next generation immunotherapies in infectious disease, immuno-oncology and auto-immune conditions.
Speaking about the move, Dr Colm Galligan, Remedy’s Chief Medical Officer said “this move allows RemedyBio to co-locate with the Trinity St James’s Cancer Institute, the first Irish cancer institute to be accredited by the Organisation of European Cancer Institutes (OECI) and with the recent Science Foundation Ireland funded AIB Trinity Covid-19 Research Hub. Both these centres build on the long tradition of outstanding comprehensive patient care delivered at Ireland’s largest academic health campus at St James’s Hospital in central Dublin, with the immunology research excellence of Trinity College Dublin.”
